Where can I buy vosoritide in the country?

Vorasotide is a new targeted therapy for children with achondroplasia that improves height development by stimulating bone growth. It belongs to a class of selective CNP (C type natriuretic peptide) receptor agonists. It regulates chondrocyte proliferation and differentiation and slows down growth plate closure, thereby improving the growth rate of children.

Currently, Vorsolitide is not yet on the market in China, so domestic patients cannot obtain the drug directly through hospital pharmacies or formal channels. Since the drug has not yet entered the domestic drug approval and circulation system, if patients want to use vosolitide, they need to pay attention to relevant information from international clinical trials or overseas medical channels to understand possible ways to obtain it.

In overseas markets, Vorsolitide has been marketed, especially in Europe and some American countries. The price of the original drug in the European market is about RMB 69,000 per box, and there are currently no substitutes for generic drugs. Therefore, overseas purchase costs are higher, and prescriptions and compliance channels from legal medical institutions are required to ensure drug quality and transportation safety.

For domestic patients, while waiting for the domestic launch, they can learn about participation opportunities by paying attention to internationally registered clinical trials (clinicaltrials.gov and other platforms), while maintaining communication with professional doctors and doing a good job in disease monitoring and growth assessment. Before trying to purchase drugs overseas, you must ensure that the channels are legal and safe, and develop an individualized treatment plan under the guidance of a doctor to ensure efficacy and drug safety.

Reference materials:https://www.drugs.com/